Evidence map›Paper›PMID 34957103›Full record

ArticleFrontiers in cell and developmental biology2021

Developmental Disruption of

Candela Barettino, Álvaro Ballesteros-Gonzalez, Andrés Aylón, Xavier Soler-Sanchis, Leticia Ortí, Selene Díaz, Isabel Reillo, Francisco García-García, Francisco José Iborra, Cary Lai and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Candela BarettinoNeural Plasticity Laboratory, Príncipe Felipe Research Center, Valencia, Spain.
Álvaro Ballesteros-GonzalezNeural Plasticity Laboratory, Príncipe Felipe Research Center, Valencia, Spain.
Andrés AylónNeural Plasticity Laboratory, Príncipe Felipe Research Center, Valencia, Spain.
Xavier Soler-SanchisNeural Plasticity Laboratory, Príncipe Felipe Research Center, Valencia, Spain.
Leticia OrtíNeural Plasticity Laboratory, Príncipe Felipe Research Center, Valencia, Spain.
Selene DíazNeural Plasticity Laboratory, Príncipe Felipe Research Center, Valencia, Spain.
Isabel ReilloDevelopmental Neurobiology Unit, Instituto de Biomedicina de Valencia, IBV-CSIC, Valencia, Spain.
Francisco García-GarcíaBioinformatics and Biostatistics Unit, Príncipe Felipe Research Center (CIPF), Valencia, Spain.
Francisco José IborraNeural Plasticity Laboratory, Príncipe Felipe Research Center, Valencia, Spain.
Cary LaiDepartment of Psychological and Brain Sciences, Indiana University, Bloomington, IN, United States.
Nathalie DehorterINMED, INSERM, Aix Marseille University, Marseille, France.
Xavier LeinekugelInstitut de Neurobiology de la Méditerranée (INMED, UMR1249), INSERM, Marseille, France.
Nuria FlamesDevelopmental Neurobiology Unit, Instituto de Biomedicina de Valencia, IBV-CSIC, Valencia, Spain.
Isabel Del PinoNeural Plasticity Laboratory, Príncipe Felipe Research Center, Valencia, Spain.
Centro de Investigacion Principe Felipe · ESInstituto de Biomedicina de Valencia · ESAix-Marseille Université · FRIndiana University Bloomington · USInstitut de Neurobiologie de la Méditerranée · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The serotonergic system of mammals innervates virtually all the central nervous system and regulates a broad spectrum of behavioral and physiological functions. In mammals, serotonergic neurons located in the rostral raphe nuclei encompass diverse sub-systems characterized by specific circuitry and functional features. Substantial evidence suggest that functional diversity of serotonergic circuits has a molecular and connectivity basis. However, the landscape of intrinsic developmental mechanisms guiding the formation of serotonergic sub-systems is unclear. Here, we employed developmental disruption of gene expression specific to serotonergic subsets to probe the contribution of the tyrosine kinase receptor ErbB4 to serotonergic circuit formation and function. Through an

Indexed as

ErbB4memoryneurodevelopmental disordersneuromodulationNRGserotonin

Identifiers

PMID34957103
PMCPMC8703035
OpenAlexW4200159847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.